AstraZeneca Competitors
AZN Stock | USD 67.75 0.51 0.75% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of AstraZeneca PLC competition on your existing holdings.
AstraZeneca |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AstraZeneca PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
AstraZeneca PLC Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between AstraZeneca PLC and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of AstraZeneca and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of AstraZeneca PLC ADR does not affect the price movement of the other competitor.
CVX | MCD | BAC | AA | KO | WMT | IBM | XOM | ||
CVX | -0.57 | 0.69 | 0.07 | 0.51 | 0.71 | 0.6 | 0.83 | CVX | |
MCD | -0.57 | -0.57 | -0.18 | -0.39 | -0.48 | -0.35 | -0.66 | MCD | |
BAC | 0.69 | -0.57 | 0.39 | 0.51 | 0.77 | 0.61 | 0.94 | BAC | |
AA | 0.07 | -0.18 | 0.39 | -0.08 | -0.22 | -0.32 | 0.24 | AA | |
KO | 0.51 | -0.39 | 0.51 | -0.08 | 0.64 | 0.42 | 0.59 | KO | |
WMT | 0.71 | -0.48 | 0.77 | -0.22 | 0.64 | 0.89 | 0.85 | WMT | |
IBM | 0.6 | -0.35 | 0.61 | -0.32 | 0.42 | 0.89 | 0.71 | IBM | |
XOM | 0.83 | -0.66 | 0.94 | 0.24 | 0.59 | 0.85 | 0.71 | XOM | |
CVX | MCD | BAC | AA | KO | WMT | IBM | XOM |
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between AstraZeneca Stock performing well and AstraZeneca PLC Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AstraZeneca PLC's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CVX | 0.85 | 0.01 | (0.04) | 0.15 | 1.04 | 1.99 | 5.97 | |||
MCD | 0.72 | (0.13) | 0.00 | (0.07) | 0.00 | 1.54 | 5.99 | |||
BAC | 0.95 | 0.04 | 0.07 | 0.16 | 0.86 | 2.07 | 6.11 | |||
AA | 2.46 | (0.36) | (0.02) | 0.01 | 3.19 | 5.35 | 15.82 | |||
KO | 0.50 | 0.03 | (0.08) | 0.19 | 0.45 | 1.20 | 3.53 | |||
WMT | 0.64 | 0.17 | 0.13 | 0.66 | 0.35 | 1.46 | 4.93 | |||
IBM | 1.08 | 0.07 | 0.12 | 0.17 | 0.88 | 2.58 | 11.73 | |||
XOM | 0.88 | 0.14 | 0.08 | 0.37 | 0.80 | 2.04 | 4.66 |
Cross Equities Net Income Analysis
Compare AstraZeneca PLC ADR and related stocks such as Chevron Corp, McDonalds, and Bank Of America Net Income Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CVX | 1.6 B | 26.9 B | 26.2 B | 21.4 B | 19.2 B | 4.6 B | (497 M) | 9.2 B | 14.8 B | 2.9 B | (5.6 B) | 15.6 B | 35.5 B | 21.4 B | 11.3 B |
MCD | 433 M | 5.5 B | 5.5 B | 5.6 B | 4.8 B | 4.5 B | 4.7 B | 5.2 B | 5.9 B | 6 B | 4.7 B | 7.5 B | 6.2 B | 8.5 B | 8.9 B |
BAC | 1.1 B | 1.4 B | 2.8 B | 9.2 B | 4.5 B | 14.4 B | 16.1 B | 16.6 B | 26.7 B | 27.4 B | 17.9 B | 32 B | 27.5 B | 26.5 B | 27.8 B |
AA | (2.9 B) | (2.9 B) | (2.9 B) | (2.9 B) | (256 M) | (863 M) | (400 M) | 217 M | 227 M | (853 M) | (14 M) | 429 M | 59 M | (651 M) | (683.5 M) |
KO | 722.3 M | 8.6 B | 9 B | 8.6 B | 7.1 B | 7.4 B | 6.5 B | 1.2 B | 6.4 B | 8.9 B | 7.7 B | 9.8 B | 9.5 B | 10.7 B | 5.4 B |
WMT | 327.5 M | 15.7 B | 17 B | 16 B | 16.4 B | 14.7 B | 13.6 B | 9.9 B | 6.7 B | 14.9 B | 13.5 B | 13.7 B | 11.7 B | 15.5 B | 9.3 B |
IBM | 6.6 B | 15.9 B | 16.6 B | 16.5 B | 12 B | 13.2 B | 11.9 B | 5.8 B | 8.7 B | 9.4 B | 5.6 B | 5.7 B | 1.6 B | 7.5 B | 8 B |
XOM | 4.9 B | 41.1 B | 44.9 B | 32.6 B | 32.5 B | 16.1 B | 7.8 B | 19.7 B | 20.8 B | 14.3 B | (22.4 B) | 23 B | 55.7 B | 36 B | 20.1 B |
AstraZeneca PLC ADR and related stocks such as Chevron Corp, McDonalds, and Bank Of America Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in AstraZeneca PLC ADR financial statement analysis. It represents the amount of money remaining after all of AstraZeneca PLC ADR operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.AstraZeneca PLC Competitive Analysis
The better you understand AstraZeneca PLC competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, AstraZeneca PLC's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across AstraZeneca PLC's competition over several years is one of the best ways to analyze its investment potential.Better Than Average | Worse Than Peers | View Performance Chart |
AstraZeneca PLC Competition Performance Charts
Five steps to successful analysis of AstraZeneca PLC Competition
AstraZeneca PLC's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by AstraZeneca PLC ADR in relation to its competition. AstraZeneca PLC's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of AstraZeneca PLC in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact AstraZeneca PLC's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to AstraZeneca PLC ADR, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your AstraZeneca PLC position
In addition to having AstraZeneca PLC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumer Funds Thematic Idea Now
Consumer Funds
Funds or Etfs that invest in consumer products such as packaged goods, clothing, food, beverages and retail services. The Consumer Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Funds Theme or any other thematic opportunities.
View All Next | Launch |
Check out AstraZeneca PLC Correlation with its peers. Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.059 | Dividend Share 2.9 | Earnings Share 1.9 | Revenue Per Share 2.4547 | Quarterly Revenue Growth 0.073 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.